Status:
COMPLETED
Virtual Reality in Physical Therapy in Multiple Sclerosis
Lead Sponsor:
Charles University, Czech Republic
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The randomized controlled trial is aimed to study the efficacy of virtual reality (VR) and its impact on upper limb function and postural stability in people with mild to severe multiple sclerosis (pw...
Detailed Description
In 60 - 75% of people with multiple sclerosis (MS) an upper limb mobility dysfunction (unilateral or bilateral manual dexterity, sensibility impairment, tremor) is present, resulting in reduced partic...
Eligibility Criteria
Inclusion
- The inclusion criteria comprise of a definite diagnosis of multiple sclerosis, EDSS score ≥ 2 a ≤ 7 ((10); determined by neurologist), no history of relapse, no history of change in disease-modifying treatment, no history of corticosteroid therapy in the past three months prior to recruitment.
Exclusion
- The exclusion criteria include other factors influencing mobility (history of stroke, pregnancy, traumatic injury of limb/s. Severe cardiovascular or orthopedic dysfunction, impaired cognitive functions in the course of examination and/or consecutive therapy.
Key Trial Info
Start Date :
April 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
February 1 2025
Estimated Enrollment :
71 Patients enrolled
Trial Details
Trial ID
NCT04807738
Start Date
April 1 2021
End Date
February 1 2025
Last Update
March 7 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of neurology
Prague, Czechia, 100 00
2
Deparment of revmatology and rehabilitation
Prague, Czechia, 140 59